OptiNose, Inc.: Financial Report Reveals Stability
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
- Latest
- Trending
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Operation Ilex investigates allegations of a professor providing prohibited drugs to riders, including Miguel Ángel López. The case challenges the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.